Dyspareunia in women

American Family Physician

Volumn 90, Issue 7, 2014, Pages 465-470

  Seehusen, Dean A ^a   Baird, Drew C ^b   Bode, David V ^a  

^a EISENHOWER ARMY MEDICAL CENTER   (United States)

^b CARL R DARNALL ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL FEATURE; CONFLICT; DIFFERENTIAL DIAGNOSIS; DYSPAREUNIA; FEMALE; HEALTH; HUMAN; MEDICAL HISTORY; PELVIC EXAMINATION; PHYSICAL EXAMINATION; PHYSIOTHERAPY; POSTPARTUM DYSPAREUNIA; SEXUAL BEHAVIOR; TREATMENT PLANNING; VAGINA ATROPHY; VAGINAL LUBRICATION; VAGINISM; VULVODYNIA; WOMEN'S HEALTH;

DIAGNOSIS, DIFFERENTIAL; DYSPAREUNIA; FEMALE; HUMANS; WOMEN'S HEALTH;

EID: 84930252513     PISSN: 0002838X     EISSN: 15320650     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Lewis RW, Fugl-Meyer KS, Corona G, et al. Definitions/epidemiology/risk factors for sexual dysfunction. J Sex Med. 2010; 7(4 pt 2): 1598-1607.
2. Ferrero S, Ragni N, Remorgida V. Deep dyspareunia: causes, treatments, and results. Curr Opin Obstet Gynecol. 2008; 20(4): 394-399.
3. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors [published correction appears in JAMA. 1999; 281(13): 1174]. JAMA. 1999; 281(6): 537-544.
4. Simons JS, Carey MP. Prevalence of sexual dysfunctions: results from a decade of research. Arch Sex Behav. 2001; 30(2): 177-219.
5. van Lankveld JJ, Granot M, Weijmar Schultz WC, et al. Women's sexual pain disorders. J Sex Med. 2010; 7(1 pt 2): 615-631.
6. Basson R, Wierman ME, van Lankveld J, Brotto L. Summary of the recommendations on sexual dysfunctions in women. J Sex Med. 2010; 7 (1 pt 2): 314-326.
7. Huber JD, Pukall CF, Boyer SC, Reissing ED, Chamberlain SM. "Just relax": physicians' experiences with women who are difficult or impossible to examine gynecologically. J Sex Med. 2009; 6(3): 791-799.
8. Faubion SS, Shuster LT, Bharucha AE. Recognition and management of nonrelaxing pelvic floor dysfunction. Mayo Clin Proc. 2012; 87(2): 187-193.
9. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, Va.: American Psychiatric Association; 2013.
10. Frank JE, Mistretta P, Will J. Diagnosis and treatment of female sexual dysfunction [published correction appears in Am Fam Physician. 2009; 79(3): 180]. Am Fam Physician. 2008; 77(5): 635-642.
11. Bertolasi L, Frasson E, Cappelletti JY, Vicentini S, Bordignon M, Graziottin A. Botulinum neurotoxin type A injections for vaginismus secondary to vulvar vestibulitis syndrome. Obstet Gynecol. 2009; 114(5): 1008-1016.
12. Moyal-Barracco M, Lynch PJ. 2003 ISSVD terminology and classification of vulvodynia. J Reprod Med. 2004; 49(10): 772-777.
13. Khandker M, Brady SS, Vitonis AF, Maclehouse RF, Stewart EG, Harlow BL. The influence of depression and anxiety on risk of adult onset vulvodynia. J Womens Health (Larchmt). 2011; 20(10): 1445-1451.
14. ACOG Committee on Gynecologic Practice. ACOG Committee Opinion: Number 345, October 2006: vulvodynia. Obstet Gynecol. 2006; 108(4): 1049-1052.
15. Nunns D, Mandal D, Byrne M, et al.; British Society for the Study of Vulval Disease (BSSVD) Guideline Group. Guidelines for the management of vulvodynia [published correction appears in Br J Dermatol. 2010; 162(6): 1416]. Br J Dermatol. 2010; 162(6): 1180-1185.
16. Andrews JC. Vulvodynia interventions-systematic review and evidence grading. Obstet Gynecol Surv. 2011; 66(5): 299-315.
17. Reed BD, Caron AM, Gorenflo DW, Haefner HK. Treatment of vulvodynia with tricyclic antidepressants: efficacy and associated factors. J Low Genit Tract Dis. 2006; 10(4): 245-251.
18. Zolnoun DA, Hartmann KE, Steege JF. Overnight 5% lidocaine ointment for treatment of vulvar vestibulitis. Obstet Gynecol. 2003; 102(1): 84-87.
19. Boardman LA, Stockdale CK. Sexual pain. Clin Obstet Gynecol. 2009; 52(4): 682-690.
20. Stika CS. Atrophic vaginitis. Dermatol Ther. 2010; 23(5): 514-522.
21. Signorello LB, Harlow BL, Chekos AK, Repke JT. Postpartum sexual functioning and its relationship to perineal trauma. Am J Obstet Gynecol. 2001; 184(5): 881-888.
22. Leeman LM, Rogers RG. Sex after childbirth: postpartum sexual function. Obstet Gynecol. 2012; 119(3): 647-655.
23. Woodward AP, Matthews CA. Outcomes of revision perineoplasty for persistent postpartum dyspareunia. Female Pelvic Med Reconstr Surg. 2010; 16(2): 135-139.
24. MacBride MB, Rhodes DJ, Shuster LT. Vulvovaginal atrophy. Mayo Clin Proc. 2010; 85(1): 87-94.
25. Krychman ML. Vaginal estrogens for the treatment of dyspareunia. J Sex Med. 2011; 8(3): 666-674.
26. Reiter S. Barriers to effective treatment of vaginal atrophy with local estrogen therapy. Int J Gen Med. 2013; 6: 153-158.
27. Suckling J, Lethaby A, Kennedy R. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev. 2006; (4): CD001500.
28. Soe LH, Wurz GT, Kao CJ, DeGregorio MW. Ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy: potential benefits in bone and breast. Int J Womans Health. 2013; 5: 605-611.